JPMorgan upgrades Telecom Argentina stock rating on deal progress By Investing.com

JPMorgan upgraded Telecom Argentina to Overweight and lifted its price target to $16 from $12, implying about 43% upside from the current $11.19 share price. The call is driven by expected synergies from the pending Telefonica Argentina acquisition, with antitrust review nearing completion and a potential divestiture package that JPMorgan believes could preserve a three-player market structure. Separately, the company reported Q4 2025 EPS of $0.0218 versus $0.001 expected and revenue of $1.53B versus $1.51B expected, though the stock fell in aftermarket trading.

Analysis

The market is still pricing Telecom Argentina as a domestic utility, but the antitrust path creates a re-rating regime rather than a simple earnings beat. If the transaction closes with only a modest forced divestiture, the key upside is not just scale — it is pricing discipline in a structurally less competitive mobile market, which can lift ARPU and churn metrics faster than headline synergies show up in reported EPS. The combination also increases operating leverage to any stabilization in FX and local inflation, making near-term earnings quality more important than absolute revenue growth.

The more interesting second-order effect is on América Móvil: even if the regulator preserves a theoretical three-player structure, the practical loss of share and spectrum density can compress AMX’s willingness to fight on price in Argentina. That matters because telecom competition is often won by capex intensity, not market share optics; if TEO emerges with a cleaner balance sheet and a stronger spectrum position, the incumbent competitive response could rationally shift from acquisition to harvest. That would support TEO margins for several quarters, not just one reporting cycle.

The main risk is regulatory slippage or a harsher-than-expected remedy package that turns this into a value-destructive integration. The market is likely to reward closing, not aspirational synergies, so any delay beyond the next 1-2 months can de-rate the stock as event premium decays while execution risk stays unresolved. If divestitures prove deeper than expected, the trade becomes less about market structure and more about whether management can monetize synergies quickly enough to offset lost assets.

Consensus may be underestimating how much of the upside is already contingent on a benign macro backdrop in Argentina. The upgrade thesis works best if inflation cools and FX volatility stays contained; otherwise the reported synergy benefit can be masked by working-capital drag and capex needs. In other words, this is a catalyst-driven long, but not a clean fundamental compounding story yet.

Key Decisions for Investors

• Long TEO vs short AMX on a 1-3 month horizon: express the view that Argentina consolidation benefits the stronger local operator more than the regional incumbent. Target 15-25% relative upside if approval lands with limited remedies; stop if the regulator forces a materially dilutive break-up.
• Buy TEO call spreads into the expected May decision window: e.g., 3-6 month upside structure to capture event premium while limiting downside if approval slips. Best risk/reward if implied volatility remains below realized event risk.
• Add TEO only on pullbacks below the pre-decision range rather than chasing strength: the trade should be entered when the market overprices delay risk, not after a headline approval. Use a time stop of 4-6 weeks if no regulatory clarity emerges.
• Reduce/hedge AMX exposure if Argentina is a meaningful earnings contributor: the risk is not just lost share, but a slower strategic response to a less competitive market that can cap local growth assumptions for multiple quarters.
• If the deal closes cleanly, rotate from event beta into a medium-term hold in TEO for margin expansion: the post-close setup favors 6-12 month appreciation as synergy realization and reduced pricing pressure feed through to reported EBITDA.